IRF3 and IRF7 mediate neovascularization via inflammatory cytokines

por Simons, Karin H., de Vries, Margreet R., de Jong, Rob C. M., Peters, Hendrika A. B., Jukema, J. Wouter, Quax, Paul H. A.
Publicado 2019

Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response

por de Jong, Rob C. M., Pluijmert, Niek J., de Vries, Margreet R., Pettersson, Knut, Atsma, Douwe E., Jukema, J. Wouter, Quax, Paul H. A.
Publicado 2018

Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory Response

por Pluijmert, Niek J., de Jong, Rob C.M., de Vries, Margreet R., Pettersson, Knut, Atsma, Douwe E., Jukema, J. Wouter, Quax, Paul H.A.
Publicado 2020

P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3(*)Leiden Mice via Systemic Inhibition of Regulatory T Cells

por de Jong, Alwin, de Jong, Rob C. M., Peters, Erna A., Arens, Ramon, Jukema, J. Wouter, de Vries, Margreet R., Quax, Paul H. A.
Publicado 2021

Phosphorylcholine antibodies restrict infarct size and left ventricular remodelling by attenuating the unreperfused post‐ischaemic inflammatory response

por Pluijmert, Niek J., de Jong, Rob C. M., de Vries, Margreet R., Pettersson, Knut, Atsma, Douwe E., Jukema, J. Wouter, Quax, Paul H. A.
Publicado 2021

Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization

por Baganha, Fabiana, de Jong, Rob C. M., Peters, Erna A., Voorham, Wietske, Jukema, J. Wouter, Delibegovic, Mirela, de Vries, Margreet R., Quax, Paul H. A.
Publicado 2021

The Prebiotic Inulin Aggravates Accelerated Atherosclerosis in Hypercholesterolemic APOE*3-Leiden Mice

por Hoving, Lisa R., de Vries, Margreet R., de Jong, Rob C. M., Katiraei, Saeed, Pronk, Amanda, Quax, Paul H. A., van Harmelen, Vanessa, Willems van Dijk, Ko
Publicado 2018

Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors( )

por Huisman, Wesley, Gille, Ilse, van der Maarel, Lieve E, Hageman, Lois, Morton, Laura T, de Jong, Rob C M, Heemskerk, Mirjam H M, Amsen, Derk, Falkenburg, J H Frederik, Jedema, Inge
Publicado 2020

Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts

por Baganha, Fabiana, Sluiter, Thijs J., de Jong, Rob C. M., van Alst, Louise A., Peters, Hendrika A. B., Jukema, J. Wouter, Delibegovic, Mirela, Pettersson, Knut, Quax, Paul H. A., de Vries, Margreet R.
Publicado 2022

The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development

por de Jong, Rob C. M., Ewing, Mark M., de Vries, Margreet R., Karper, Jacco C., Bastiaansen, Antonius J. N. M., Peters, Hendrika A. B., Baghana, Fabiana, van den Elsen, Peter J., Gongora, Céline, Jukema, J. Wouter, Quax, Paul H. A.
Publicado 2017

TLR4 Accessory Molecule RP105 (CD180) Regulates Monocyte-Driven Arteriogenesis in a Murine Hind Limb Ischemia Model

por Bastiaansen, Antonius J. N. M., Karper, Jacco C., Wezel, Anouk, de Boer, Hetty C., Welten, Sabine M. J., de Jong, Rob C. M., Peters, Erna A. B., de Vries, Margreet R., van Oeveren-Rietdijk, Annemarie M., van Zonneveld, Anton Jan, Hamming, Jaap F., Nossent, A. Yaël, Quax, Paul H. A.
Publicado 2014

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML

por van der Lee, Dyantha I., Koutsoumpli, Georgia, Reijmers, Rogier M., Honders, M. Willy, de Jong, Rob C. M., Remst, Dennis F. G., Wachsmann, Tassilo L. A., Hagedoorn, Renate S., Franken, Kees L. M. C., Kester, Michel G. D., Harber, Karl J., Roelofsen, Lisanne M., Schouten, Annemiek M., Mulder, Arend, Drijfhout, Jan W., Veelken, Hendrik, van Veelen, Peter A., Heemskerk, Mirjam H. M., Falkenburg, J. H. Frederik, Griffioen, Marieke
Publicado 2021